CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Growing number of cancer patients
3.4.1.2. Increasing ageing population
3.4.1.3. Rising awareness and increasing adoption of radiotherapy devices and procedures
3.4.1.4. Technological advancements in radiotherapy devices
3.4.2. Restraints
3.4.2.1. Dearth of skilled personnel
3.4.2.2. Difficulty in tumor visualization
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.4.3.2. Increasing demand for cancer treatment
3.4.4. Impact analysis
3.5. CLINICAL TRIALS
CHAPTER 4 GLOBAL RADIOTHERAPY MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. EXTERNAL BEAM RADIATION THERAPY
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. External beam radiation therapy market, by product
4.2.5. Market size and forecast
4.2.5.1. Compact advanced radiotherapy systems
4.2.5.1.1. Market size and forecast
4.2.5.1.2. CyberKnife
4.2.5.1.2.1. Market size and forecast
4.2.5.1.3. Gamma Knife
4.2.5.1.3.1. Market size and forecast
4.2.5.1.4. Tomotherapy
4.2.5.1.4.1. Market size and forecast
4.2.5.2. Proton therapy systems
4.2.5.2.1. Market size and forecast
4.2.5.3. Conventional radiotherapy systems
4.2.5.3.1. Market size and forecast
4.2.6. External beam radiation therapy, by technology
4.2.7. Market size and forecast
4.2.7.1. 3D Conformal Radiotherapy (3D CRT)
4.2.7.1.1. Market size & forecast
4.2.7.2. Image-Guided Radiotherapy (IGRT)
4.2.7.2.1. Market size & forecast
4.2.7.3. Intensity Modulated Radiotherapy (IMRT)
4.2.7.3.1. Market size & forecast
4.2.7.4. Stereotactic Technology
4.2.7.4.1. Market size & forecast
4.2.7.5. Proton Beam Therapy
4.2.7.5.1. Market size & forecast
4.2.7.6. Volumetric Modulated Arc Therapy (VMAT)
4.2.7.6.1. Market size & forecast
4.2.8. External beam radiation therapy, by application
4.2.9. Market size & forecast
4.2.9.1. Prostate Cancer
4.2.9.1.1. Market size & forecast
4.2.9.2. Breast Cancer
4.2.9.2.1. Market size & forecast
4.2.9.3. Lung Cancer
4.2.9.3.1. Market size & forecast
4.2.9.4. Colorectal Cancer
4.2.9.4.1. Market size & forecast
4.2.9.5. Other
4.2.9.5.1. Market size & forecast
4.3. INTERNAL RADIATION THERAPY/BRACHYTHERAPY
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Brachytherapy market, by product
4.3.5. Market size and forecast
4.3.5.1. Implants & applicators
4.3.5.1.1. Market size and forecast
4.3.5.2. Electronic brachytherapy devices
4.3.5.2.1. Market size and forecast
4.3.6. Brachytherapy market, by technology
4.3.7. Market size and forecast
4.3.7.1. Low dose rate
4.3.7.1.1. Market size and forecast
4.3.7.2. High dose rate
4.3.7.2.1. Market size and forecast
4.3.8. Brachytherapy market, by application
4.3.9. Market size and forecast
4.3.9.1. Prostate cancer
4.3.9.1.1. Market size and forecast
4.3.9.2. Gynecological cancer
4.3.9.2.1. Market size and forecast
4.3.9.3. Breast cancer
4.3.9.3.1. Market size and forecast
4.3.9.4. Other
4.3.9.4.1. Market size and forecast
4.4. SYSTEMIC RADIATION THERAPY
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 RADIOTHERAPY MARKET, BY END USER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITALS & CLINICS
5.2.1. Market size and forecast
5.3. AMBULATORY SURGICAL CENTERS (ASCS)
5.3.1. Market size and forecast
CHAPTER 6 RADIOTHERAPY MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.
6.2.5. Canada
6.2.6. Mexico
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany
6.3.5. France
6.3.6. UK
6.3.7. Italy
6.3.8. Spain
6.3.9. Rest of Europe
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan
6.4.5. China
6.4.6. India
6.4.7. South Korea
6.4.8. Australia
6.4.9. Rest of Asia-Pacific
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil
6.5.5. South Africa
6.5.6. Saudi Arabia
6.5.7. Rest of LAMEA
CHAPTER 7 COMPANY PROFILES
7.1. ACCURAY INCORPORATED
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.7. Key strategic moves and developments
7.2. C. R. BARD, INC.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Key strategic moves and developments
7.3. ELEKTA AB
7.3.1. Company overview
7.3.2. Company Snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.7. Key strategic moves and developments
7.4. IBA (ION BEAM APPLICATIONS SA)
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Key strategic moves and developments
7.5. ISORAY MEDICAL, INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.7. Key strategic moves and developments
7.6. MEVION MEDICAL SYSTEMS, INC.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.7. Key strategic moves and developments
7.7. MITSUBISHI ELECTRIC CORPORATION
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Key strategic moves and developments
7.8. NORDION, INC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Key strategic moves and developments
7.9. RAYSEARCH LABORATORIES AB
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating product categories
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. VARIAN MEDICAL SYSTEMS, INC.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio